Sarah Mosier

Emergence and Evolution of Enfuvirtide Resistance following Long-Term Therapy Involves Heptad Repeat 2 Mutations within gp41

Li Xu, Anton Pozniak, Adrian Wildfire et al. · Antimicrobial Agents and Chemotherapy · 2005 · 168 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates

Prakash Sista, Tom Melby, Donna K. Davison et al. · AIDS · 2004 · 154 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

Impact of Human Immunodeficiency Virus Type 1 gp41 Amino Acid Substitutions Selected during Enfuvirtide Treatment on gp41 Binding and Antiviral Potency of Enfuvirtide In Vitro

Mike Mink, Sarah Mosier, S. Janumpalli et al. · Journal of Virology · 2005 · 129 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection.

Barbara Rehermann, C Pasquinelli, Sarah Mosier et al. · Journal of Clinical Investigation · 1995 · 121 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection

Sam Hopkins, Betty DiMassimo, Pamela Rusnak et al. · Journal of Hepatology · 2012 · 92 citations

Life Sciences, Infectious Diseases, Microbiology +14